citalopram has been researched along with hydroxyindoleacetic acid in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (15.09) | 18.7374 |
1990's | 21 (39.62) | 18.2507 |
2000's | 18 (33.96) | 29.6817 |
2010's | 6 (11.32) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gołembiowska, K; Jaworska, L; Przegaliński, E | 1 |
Baker, PC; Hoff, KM | 4 |
Gottfries, CG; Nyth, AL | 1 |
Campbell, IC; Ellison, DW | 1 |
Ciesielski, L; Gobaille, S; Isel, F; Mandel, P; Molina, V | 1 |
Cohen Stuart, MH; de Beurs, P; Høpfner Petersen, HE; Leijnse-Ybema, H; Sanchez, C; Tan, BK; Timmerman, L | 1 |
Aalto, J; Kiianmaa, K | 1 |
Dandiya, PC; Gurbani, NK; Keshavan, HJ | 1 |
Baker, PC; Goodrich, CA | 1 |
Kabuto, H; Kurimoto, T; Mori, A; Takei, M; Yokoi, I | 1 |
Endo, A; Kabuto, H; Kurimoto, T; Mori, A; Takei, M; Yokoi, I | 1 |
Bonhomme, N; De Deurwaerdère, P; Le Moal, M; Spampinato, U | 1 |
Fujishima, M; Ibayashi, S; Izumi, J; Nagao, T; Sadoshima, S | 1 |
Kreiss, DS; Lucki, I; Wieland, S | 1 |
Hjorth, S; Pettersson, G | 1 |
Collins, P; Hindmarsh, JG; Hunt, S; Jenner, P; Rose, S | 1 |
Artigas, F; Casanovas, JM | 1 |
Drujan, Y; Lima, L; Matus, P; Urbina, M | 1 |
Bergami, A; Caccia, S; Caltavuturo, C; Gobbi, M; Mennini, T; Valle, FD | 1 |
Afkhami-Dastjerdian, S; Carli, M; Reader, TA | 1 |
Aguerre, S; Berton, O; Chaouloff, F; Kulikov, A; Mormede, P; Ramos, A | 1 |
Anttila, M; Heinonen, E; Helminen, A; Huupponen, R; Laine, K; Mäki-Ikola, O; Reinikainen, K; Scheinin, M | 1 |
Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Wikell, C | 1 |
Ebinger, G; Michotte, Y; Sarre, S; Thorré, K | 1 |
Eriksson, E; Sundblad, C | 1 |
Carlsson, ML; Hjorth, S; Martin, P | 1 |
Aguerre, S; Chaouloff, F; Ebinger, G; Michotte, Y; Mormède, P; Pollier, F; Sarre, S | 1 |
Ase, AR; Botez, MI; Descarries, L; Hébert, C; LaLonde, R; Reader, TA; Strazielle, C | 1 |
Beaufour, C; Evrard, A; Fabre, V; Hamon, M; Hanoun, N; Lanfumey, L; Lesch, KP; Martres, MP; Murphy, DL; Rioux, A | 1 |
De Deurwaerdère, P; Lucas, G; Porras, G; Spampinato, U | 1 |
Butterworth, RF; Chatauret, N; Michalak, A | 1 |
Heilig, M; Möller, C; Nissbrandt, H; Rimondini, R; Sommer, W; Thorsell, A; Wiklund, L | 1 |
Ase, AR; Hébert, C; Le Marec, N; Reader, TA | 1 |
Boulay, D; Costentin, J; Leroux-Nicollet, I; Naudon, L | 1 |
Allikmets, L; Matto, V; Pruus, K; Rudissaar, R; Vaarmann, A | 1 |
Adrien, J; Boni, C; De Maeyer, E; Evrard, A; Gardier, A; Hamon, M; Hanoun, N; Laporte, AM; Malagié, I; Seif, I; Trillat, AC | 1 |
Allikmets, L; Matto, V; Pruus, K; Rudisaar, R; Vaarmann, A | 1 |
Bandpey, Z; Heiberg, IL; Mørk, A; Rosenberg, R; Wegener, G | 1 |
Baumann, P; Brawand-Amey, M; Czernik, A; Eap, CB; Jiménez-Vasquez, P; Mathé, AA; Nikisch, G | 1 |
Al Deeb, S; Al Kadasah, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M | 1 |
Jacobsen, JP; Mørk, A | 1 |
Alvarenga, M; Barton, D; Brenchley, C; Dawood, T; Esler, M; Guo, L; Haikerwal, D; Hastings, J; Jennings, G; Kalff, V; Kaye, D; Kelly, M; Lambert, E; Lambert, G; Pier, C; Richards, J; Socratous, F; Wiesner, G | 1 |
Eller, M; Häidkind, R; Harro, J; Kõiv, K; Mällo, T; Tõnissaar, M | 1 |
Adelman, JP; Bond, CT; Christophersen, P; Hansen, HH; Holst, D; Jacobsen, JP; Mikkelsen, JD; Mirza, NR; Redrobe, JP; Weikop, P | 1 |
Ali, SF; Daniels, LG; Meyer, JS; Piper, BJ | 1 |
Kaneko, S; Kitagawa, Y; Kitaichi, M; Nagayasu, K; Nakagawa, T; Shirakawa, H; Yatani, Y | 1 |
Clarke, G; Cryan, JF; Dinan, TG; Donovan, MD; Griffin, BT; O'Brien, FE; O'Connor, RM | 1 |
Chappell, JC; Dean, RA; Detke, MJ; Eisenhofer, G; Haber, H; Iyengar, S; Knadler, MP; Lachno, DR; Lobo, ED; Mitchell, MI; Nemeroff, CB; Owens, MJ; Pangallo, B | 1 |
Benazzouz, A; De Deurwaerdère, P; Delaville, C; Lagière, M; Marquis, L; Miguelez, C; Navailles, S; Ugedo, L | 1 |
Dady, KF; Hale, MW; Heinze, JD; Kelly, KJ; Lowry, CA; Lukkes, JL; Paul, ED; Raison, CL; Smith, DG | 1 |
5 trial(s) available for citalopram and hydroxyindoleacetic acid
Article | Year |
---|---|
The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.
Topics: Affective Symptoms; Aged; Alzheimer Disease; Citalopram; Dementia, Multi-Infarct; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Scandinavian and Nordic Countries | 1990 |
A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Topics: Adult; Aged; Anthracenes; Blood Platelets; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Propylamines; Serotonin | 1987 |
Lack of adverse interactions between concomitantly administered selegiline and citalopram.
Topics: Adult; Antidepressive Agents; Citalopram; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Epinephrine; Humans; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Naphthols; Norepinephrine; Placebos; Prolactin; Propylene Glycols; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin | 1997 |
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
Topics: Adult; Brain; Case-Control Studies; Catheterization, Central Venous; Catheterization, Peripheral; Cerebrovascular Circulation; Citalopram; Genotype; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Research Design; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2007 |
Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; California; Central Nervous System; Citalopram; Cross-Over Studies; Duloxetine Hydrochloride; Female; Healthy Volunteers; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Texas; Thiophenes; Young Adult | 2014 |
48 other study(ies) available for citalopram and hydroxyindoleacetic acid
Article | Year |
---|---|
The effect of p-chloroamphetamine and p-chlorophenylalanine on the level of thyrotropin-releasing hormone and its receptors in some brain structures and lumbar spinal cord of the rat.
Topics: Animals; Brain; Citalopram; Corpus Striatum; Fenclonine; Hydroxyindoleacetic Acid; Male; Nucleus Accumbens; p-Chloroamphetamine; Rats; Rats, Wistar; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Serotonin; Spinal Cord; Thyrotropin-Releasing Hormone | 1992 |
Chronic citalopram action and the maturing mouse brain's indoleamine levels.
Topics: Aging; Animals; Animals, Newborn; Brain; Brain Stem; Citalopram; Hydroxyindoleacetic Acid; Mice; Serotonin | 1990 |
The effects of acute and extended monoamine oxidase inhibition upon 5-hydroxyindoles in maturing mouse brain.
Topics: Aging; Animals; Animals, Newborn; Brain; Brain Chemistry; Brain Stem; Citalopram; Hydroxyindoleacetic Acid; Indoles; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Phenethylamines; Serotonin | 1991 |
Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzylamines; Cerebral Cortex; Citalopram; Clonidine; Clorgyline; Desipramine; Hydroxyindoleacetic Acid; Male; Maprotiline; Nomifensine; Potassium; Propylamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Synaptosomes; Yohimbine | 1986 |
The recovery of maturing brain from acute citalopram exposure.
Topics: Animals; Brain; Citalopram; Hydroxyindoleacetic Acid; Indoles; Mice; Propylamines; Serotonin; Serotonin Antagonists | 1987 |
Inhibition of mouse killing behavior by serotonin-mimetic drugs: effects of partial alterations of serotonin neurotransmission.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Animals; Citalopram; Fenclonine; Fluoxetine; Hydroxyindoleacetic Acid; Male; Methoxydimethyltryptamines; Motor Activity; Propylamines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Tetrahydronaphthalenes | 1987 |
Role of brain monoaminergic systems in the increased ethanol drinking caused by REM-sleep deprivation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Animals; Brain Chemistry; Catecholamines; Citalopram; Dopamine; Hydroxyindoleacetic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Piperazines; Prazosin; Propylamines; Rats; Serotonin; Sleep Deprivation; Sleep, REM; Thiophenes | 1987 |
Indoleamine stores in maturing mouse brain reexposed to citalopram following extended uptake inhibition.
Topics: Aging; Animals; Animals, Newborn; Brain Chemistry; Brain Stem; Citalopram; Hydroxyindoleacetic Acid; Indoles; Mice; Mice, Inbred Strains; Organ Size; Serotonin; Serotonin Antagonists | 1988 |
Effect of citalopram (Lu 10-171) on tranylcypromine and tryptophan-induced wet-dog shakes in rats.
Topics: Animals; Behavior, Animal; Benzofurans; Brain Chemistry; Citalopram; Drug Interactions; Female; Hydroxyindoleacetic Acid; Male; Norepinephrine; Propylamines; Rats; Serotonin; Tranylcypromine; Tryptophan | 1980 |
The effects of the specific uptake inhibitor Lu 10-171 (citalopram) upon brain indoleamine stores in the maturing mouse.
Topics: 5-Hydroxytryptophan; Aging; Animals; Brain; Citalopram; Hydrazines; Hydroxyindoleacetic Acid; Mice; Propylamines; Serotonin; Serotonin Antagonists | 1982 |
The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain.
Topics: Animals; Anticonvulsants; Brain; Cerebral Cortex; Citalopram; Corpus Striatum; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Kynurenic Acid; Mice; Mice, Neurologic Mutants; Seizures; Serotonin; Tryptophan; Tyrosine | 1994 |
Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity.
Topics: Administration, Oral; Animals; Anticonvulsants; Brain; Citalopram; Disease Models, Animal; Epilepsy; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Mice; Mice, Neurologic Mutants; Monoamine Oxidase; Serotonin; Time Factors; Tryptophan Hydroxylase | 1994 |
d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Anesthesia; Animals; Citalopram; Corpus Striatum; Dialysis; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fenfluramine; Halothane; Hydroxyindoleacetic Acid; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Serotonin; Tetrodotoxin | 1995 |
Citalopram, a serotonin reuptake inhibitor, and brain ischemia in SHR.
Topics: Animals; Blood Pressure; Body Temperature; Brain Chemistry; Brain Ischemia; Cerebrovascular Circulation; Citalopram; Female; Hydroxyindoleacetic Acid; Hypertension; Rats; Rats, Inbred SHR; Respiratory Mechanics; Selective Serotonin Reuptake Inhibitors; Serotonin | 1995 |
The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Anesthesia; Animals; Chromatography, High Pressure Liquid; Citalopram; Corpus Striatum; Dialysis; Electrochemistry; Fenfluramine; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sodium Channels; Tetrodotoxin | 1993 |
5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Topics: Animals; Brain; Calcium; Citalopram; Hippocampus; Hydroxyindoleacetic Acid; Male; Neurons; Nicotinic Acids; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of rats.
Topics: Animals; Appetite Depressants; Binding Sites; Biomarkers; Cerebral Cortex; Citalopram; Fenfluramine; GAP-43 Protein; Glial Fibrillary Acidic Protein; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Nerve Degeneration; Nerve Fibers; Nerve Regeneration; Nerve Tissue Proteins; Neurotoxins; Rats; Rats, Wistar; Serotonin | 1996 |
Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways.
Topics: Animals; Citalopram; Corpus Striatum; Dose-Response Relationship, Drug; Frontal Lobe; Hippocampus; Hydroxyindoleacetic Acid; Male; Neurons; Organ Specificity; Pyrimidines; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists | 1996 |
Synthesis of serotonin from 5-hydroxytryptophan in the post-crush retina: inhibition of in vitro outgrowth by the intraocular administration of the precursor.
Topics: 5-Hydroxytryptophan; Animals; Chromatography, High Pressure Liquid; Citalopram; Goldfish; Hydroxyindoleacetic Acid; Imipramine; Injections; Kinetics; Nerve Crush; Nerve Regeneration; Neurons; Optic Nerve; Organ Culture Techniques; Retina; Serotonin; Time Factors | 1996 |
Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brain.
Topics: Administration, Oral; Animals; Brain; Citalopram; Fenfluramine; Hydroxyindoleacetic Acid; Male; Rats; Serotonin | 1996 |
Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cell Membrane; Cerebral Cortex; Citalopram; Humans; Hydroxyindoleacetic Acid; Lithium; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Tritium | 1997 |
Central serotonergic systems in the spontaneously hypertensive and Lewis rat strains that differ in the elevated plus-maze test of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Behavior, Animal; Citalopram; Female; Hippocampus; Hydroxyindoleacetic Acid; Ketanserin; Male; Mesencephalon; Rats; Rats, Inbred Lew; Rats, Inbred SHR; Receptors, Serotonin; Serotonin; Tritium; Tryptophan Hydroxylase | 1997 |
Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
Topics: Animals; Antidepressive Agents; Biotransformation; Brain Chemistry; Citalopram; Extracellular Space; Hepatic Encephalopathy; Hydroxyindoleacetic Acid; Injections; Injections, Subcutaneous; Male; Microdialysis; Neocortex; Potassium Chloride; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |
Characterization of the extracellular serotonin release in the substantia nigra of the freely moving rat using microdialysis.
Topics: Animals; Calcium; Citalopram; Exocytosis; Hydroxyindoleacetic Acid; Male; Microdialysis; Movement; Perfusion; Potassium; Punctures; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Substantia Nigra; Tetrodotoxin | 1997 |
Reduced extracellular levels of serotonin in the amygdala of androgenized female rats.
Topics: Amygdala; Animals; Animals, Newborn; Citalopram; Female; Hydroxyindoleacetic Acid; Progesterone; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Testosterone | 1997 |
Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.
Topics: Animals; Brain Chemistry; Citalopram; Dialysis Solutions; Drug Administration Routes; Extracellular Space; gamma-Aminobutyric Acid; Hippocampus; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Male; Microdialysis; Perfusion; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin; Wakefulness | 1998 |
Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.
Topics: Animals; Brain; Citalopram; Corpus Striatum; Emotions; Hippocampus; Hydroxyindoleacetic Acid; Male; Maze Learning; Microdialysis; Organ Specificity; Rats; Rats, Inbred Lew; Rats, Inbred SHR; Rats, Inbred WKY; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity | 2000 |
Central serotonin system in Dystonia musculorum mutant mice: biochemical, autoradiographic and immunocytochemical data.
Topics: 5-Hydroxytryptophan; Animals; Autoradiography; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Dystonic Disorders; Hydroxyindoleacetic Acid; Hydroxytryptophol; Immunohistochemistry; Male; Mice; Mice, Neurologic Mutants; Organ Specificity; Serotonin; Spinal Cord; Tritium | 2000 |
Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
Topics: Animals; Autoreceptors; Binding, Competitive; Brain Chemistry; Carrier Proteins; Citalopram; Dipeptides; Down-Regulation; Gene Expression; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Oxadiazoles; Piperazines; Pyridines; Pyrimidines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Spiro Compounds; Substantia Nigra; Sulfur Radioisotopes; Synaptic Transmission; Tritium | 2000 |
Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated.
Topics: 5,7-Dihydroxytryptamine; Animals; Citalopram; Corpus Striatum; Dopamine; Fluoxetine; Hippocampus; Hydroxyindoleacetic Acid; Male; Microdialysis; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Substantia Nigra | 2000 |
Evidence for a serotonin transporter deficit in experimental acute liver failure.
Topics: Acute Disease; Animals; Binding Sites; Carrier Proteins; Citalopram; Hepatic Encephalopathy; Hydroxyindoleacetic Acid; Ischemia; Liver Circulation; Liver Failure; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tissue Distribution; Tryptophan | 2001 |
Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption.
Topics: 5,7-Dihydroxytryptamine; Amygdala; Animals; Autoradiography; Avoidance Learning; Behavior, Animal; Binding, Competitive; Carrier Proteins; Choice Behavior; Citalopram; Drinking Behavior; Ethanol; Hydroxyindoleacetic Acid; Male; Maze Learning; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Tissue Proteins; Neurotransmitter Agents; Punishment; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 2001 |
Distribution of serotonin, its metabolites and 5-HT transporters in the neostriatum of Lurcher and weaver mutant mice.
Topics: Animals; Autoradiography; Carrier Proteins; Chromatography, High Pressure Liquid; Citalopram; Electrochemistry; Heterozygote; Homozygote; Hydroxyindoleacetic Acid; Hydroxytryptophol; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Neurologic Mutants; Neostriatum; Nerve Tissue Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Tissue Distribution | 2001 |
Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Chromatography, High Pressure Liquid; Citalopram; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Kainic Acid; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2001 |
Role of 5-HT1A receptors in the mediation of acute citalopram effects: a 8-OH-DPAT challenge study.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Brain; Citalopram; Drug Synergism; Exploratory Behavior; Female; Hydroxyindoleacetic Acid; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 2002 |
Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.
Topics: Action Potentials; Animals; Autoreceptors; Brain; Carrier Proteins; Citalopram; Down-Regulation; Extracellular Space; Female; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Monoamine Oxidase; Nerve Tissue Proteins; Neurons; Raphe Nuclei; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Tritium | 2002 |
1-(1-naphthyl)-piperazine, a mixed 5-HT1A and 5-HT2A/2C receptor ligand, elicits an anxiolytic-like effect in the open-field test without changes in 5-HT metabolism.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Citalopram; Drug Interactions; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Male; Microdialysis; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists | 2002 |
Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Citalopram; Hippocampus; Hydroxyindoleacetic Acid; Lithium; Male; Rats; Rats, Sprague-Dawley; Serotonin | 2003 |
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
Topics: Adult; Chi-Square Distribution; Citalopram; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Linear Models; Male; Middle Aged; Statistics, Nonparametric; Stereoisomerism | 2004 |
Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Citalopram; Dose-Response Relationship, Drug; Drug Synergism; Electromyography; Female; Harmaline; Hydroxyindoleacetic Acid; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Tremor | 2004 |
The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Citalopram; Desipramine; Electroshock; Gene Expression Regulation; Hydroxyindoleacetic Acid; Lithium; Male; Proteins; Rats; Rats, Wistar; RNA, Messenger; Seizures; Serotonin | 2004 |
Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Biogenic Monoamines; Brain Injuries; Citalopram; Disease Models, Animal; Drug Interactions; Exploratory Behavior; Food Preferences; Frontal Lobe; Hydroxyindoleacetic Acid; Interpersonal Relations; Male; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Sucrose; Swimming | 2008 |
SK3 K+ channel-deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors.
Topics: Animals; Anti-Bacterial Agents; Anxiety Disorders; Behavior, Animal; Brain; Citalopram; Dopamine; Doxycycline; Emotions; Exploratory Behavior; Female; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurocognitive Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sex Characteristics; Small-Conductance Calcium-Activated Potassium Channels; Synaptic Transmission | 2008 |
Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
Topics: Age Factors; Animals; Binding, Competitive; Body Temperature; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever; Hippocampus; Hydroxyindoleacetic Acid; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 2010 |
Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
Topics: Action Potentials; Animals; Antidepressive Agents; Autoreceptors; Brain; Calcium; Citalopram; Extracellular Space; Fluoxetine; Hydroxyindoleacetic Acid; Organ Culture Techniques; Paroxetine; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tryptophan Hydroxylase | 2010 |
The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Cyclosporine; Disease Models, Animal; Drug Combinations; Electrochemistry; Enzyme Inhibitors; Hindlimb Suspension; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Motor Activity; Rats; Rats, Sprague-Dawley; Serotonin Syndrome | 2014 |
L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
Topics: Action Potentials; Animals; Antiparkinson Agents; Cholestanols; Citalopram; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Hippocampus; Hydroxyindoleacetic Acid; Levodopa; Male; Organ Specificity; Parkinson Disease; Prefrontal Cortex; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Single-Cell Analysis; Synaptic Transmission | 2016 |
Interactions between whole-body heating and citalopram on body temperature, antidepressant-like behaviour, and neurochemistry in adolescent male rats.
Topics: Animals; Antidepressive Agents; Body Temperature; Citalopram; Combined Modality Therapy; Depressive Disorder; Disease Models, Animal; Hydroxyindoleacetic Acid; Hyperthermia, Induced; Male; Prefrontal Cortex; Rats, Wistar; Serotonin | 2019 |